Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.

Campi-Azevedo AC, Peruhype-Magalhāes V, Coelho-Dos-Reis JG, Antonelli LR, Costa-Pereira C, Speziali E, Reis LR, Lemos JA, Ribeiro JGL, Bastos Camacho LA, de Sousa Maia ML, Barbosa de Lima SM, Simões M, de Menezes Martins R, Homma A, Cota Malaquias LC, Tauil PL, Costa Vasconcelos PF, Martins Romano AP, Domingues CM, Teixeira-Carvalho A, Martins-Filho OA; Collaborative Group for Studies of Yellow Fever Vaccine.

Emerg Infect Dis. 2019 Aug;25(8):1511-1521. doi: 10.3201/eid2508.181432. Epub 2019 Aug 17.

2.

Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study.

de Menezes Martins R, Maia MLS, de Lima SMB, de Noronha TG, Xavier JR, Camacho LAB, de Albuquerque EM, Farias RHG, da Matta de Castro T, Homma A; Collaborative Group for Studies on Duration of Immunity from Yellow Fever Vaccine.

Vaccine. 2018 Jun 27;36(28):4112-4117. doi: 10.1016/j.vaccine.2018.05.041. Epub 2018 May 18.

3.

Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.

Vergnano S, Buttery J, Cailes B, Chandrasekaran R, Chiappini E, Clark E, Cutland C, de Andrade SD, Esteves-Jaramillo A, Guinazu JR, Jones C, Kampmann B, King J, Kochhar S, Macdonald N, Mangili A, de Menezes Martins R, Velasco Muñoz C, Padula M, Muñoz FM, Oleske J, Sanicas M, Schlaudecker E, Spiegel H, Subelj M, Sukumaran L, Tagbo BN, Top KA, Tran D, Heath PT; Brighton Collaboration Neonatal Infections Working Group.

Vaccine. 2016 Dec 1;34(49):6038-6046. doi: 10.1016/j.vaccine.2016.03.046. Epub 2016 Aug 1.

4.

Serious adverse events associated with yellow fever vaccine.

de Menezes Martins R, Fernandes Leal Mda L, Homma A.

Hum Vaccin Immunother. 2015;11(9):2183-7. doi: 10.1080/21645515.2015.1022700.

5.

Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in healthy Brazilian infants: a randomized non-inferiority study.

de Menezes Martins R, Curran B, Maia Mde L, Ribeiro Md, Camacho LA, da Silva Freire M, Yamamura AM, Siqueira MM, Lemos MC, de Albuquerque EM, von Doellinger Vdos R, Homma A, Saganic L, Jarrahian C, Royals M, Zehrung D.

Contemp Clin Trials. 2015 Mar;41:1-8. doi: 10.1016/j.cct.2014.11.014. Epub 2014 Dec 1.

6.

17DD and 17D-213/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children.

Campi-Azevedo AC, de Araújo-Porto LP, Luiza-Silva M, Batista MA, Martins MA, Sathler-Avelar R, da Silveira-Lemos D, Camacho LA, de Menezes Martins R, de Lourdes de Sousa Maia M, Farias RH, da Silva Freire M, Galler R, Homma A, Ribeiro JG, Lemos JA, Auxiliadora-Martins M, Caldas IR, Elói-Santos SM, Teixeira-Carvalho A, Martins-Filho OA.

PLoS One. 2012;7(12):e49828. doi: 10.1371/journal.pone.0049828. Epub 2012 Dec 10.

7.

Cytokine signatures of innate and adaptive immunity in 17DD yellow fever vaccinated children and its association with the level of neutralizing antibody.

Luiza-Silva M, Campi-Azevedo AC, Batista MA, Martins MA, Avelar RS, da Silveira Lemos D, Bastos Camacho LA, de Menezes Martins R, de Lourdes de Sousa Maia M, Guedes Farias RH, da Silva Freire M, Galler R, Homma A, Leite Ribeiro JG, Campos Lemos JA, Auxiliadora-Martins M, Eloi-Santos SM, Teixeira-Carvalho A, Martins-Filho OA.

J Infect Dis. 2011 Sep 15;204(6):873-83. doi: 10.1093/infdis/jir439.

PMID:
21849284
8.

Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Gidudu J, Sack DA, Pina M, Hudson MJ, Kohl KS, Bishop P, Chatterjee A, Chiappini E, Compingbutra A, da Costa C, Fernandopulle R, Fischer TK, Haber P, Masana W, de Menezes MR, Kang G, Khuri-Bulos N, Killion LA, Nair C, Poerschke G, Rath B, Salazar-Lindo E, Setse R, Wenger P, Wong VC, Zaman K; Brighton Collaboration Diarrhea Working Group.

Vaccine. 2011 Jan 29;29(5):1053-71. doi: 10.1016/j.vaccine.2010.11.065. Epub 2010 Dec 3. No abstract available.

PMID:
21130754
9.

Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination.

Silva ML, Espírito-Santo LR, Martins MA, Silveira-Lemos D, Peruhype-Magalhães V, Caminha RC, de Andrade Maranhão-Filho P, Auxiliadora-Martins M, de Menezes Martins R, Galler R, da Silva Freire M, Marcovistz R, Homma A, Teuwen DE, Elói-Santos SM, Andrade MC, Teixeira-Carvalho A, Martins-Filho OA.

Clin Vaccine Immunol. 2010 Jan;17(1):118-26. doi: 10.1128/CVI.00369-09. Epub 2009 Nov 11.

10.

Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: case definition and guidelines for data collection, analysis, and presentation.

Buettcher M, Heininger U, Braun M, Bonhoeffer J, Halperin S, Heijbel H, de Menezes Martins R, Vermeer-de Bondt P; Brighton Collaboration HHE Working Group.

Vaccine. 2007 Aug 1;25(31):5875-81. Epub 2007 May 8. No abstract available.

PMID:
17537554

Supplemental Content

Loading ...
Support Center